# Endo Vitd No Screening Dark Complexion

> The guideline recommends against routine 25(OH)D screening and subsequent vitamin D treatment in adults with dark complexion who lack established indications for testing. Consider this recommendation when clinicians ask, "Should I screen for vitamin D deficiency in this patient with dark skin?" or "Is vitamin D testing indicated based on skin complexion?"

- Skill: `dromlakhani/endo-vitd-no-screening-dark-complexion` (Agent Skill)
- Install (CLI): `npx skillmds@latest add dromlakhani/endo-vitd-no-screening-dark-complexion`
- Raw SKILL.md: https://api.skillmd.com/api/skills/dromlakhani/endo-vitd-no-screening-dark-complexion/raw
- Safety review: pending (external: skill-scanner PASS, skillspector PASS)
- Works with: Claude Code, Claude.ai, OpenAI Codex
- Category: Coding & Dev Tools
- Author: dromlakhani (https://skillmd.com/u/dromlakhani)
- Updated: 2026-09-08
- Page: https://skillmd.com/skills/dromlakhani/endo-vitd-no-screening-dark-complexion

---


# Against routine vitamin D screening in dark complexion adults

## STEP 1 — Gather Information
Collect patient age, observed or self-reported dark complexion (e.g., Fitzpatrick V-VI), presence of established indications for 25(OH)D testing (hypocalcemia, malabsorption, chronic kidney disease, etc.), and pregnancy status.
Action: If the patient is an adult with dark complexion and lacks established indications for testing, proceed to Step 2.

## STEP 2 — Rule In / Rule Out
If any established indication for 25(OH)D testing is present (e.g., hypocalcemia, malabsorption, renal osteodystrophy), rule in: proceed to targeted testing per standard of care (outside this guideline). Otherwise, rule out routine screening and proceed to Step 3.

## STEP 3 — Classify or Stratify
Classify the patient as a candidate for empiric vitamin D supplementation only if they belong to a group with a guideline recommendation for empiric supplementation (age 1‑18 years, ≥75 years, pregnancy, or high‑risk prediabetes); otherwise classify as not indicated for empiric supplementation.
Action: If classified as a candidate for empiric supplementation, proceed to Step 4A; if not, proceed to Step 4B.

## STEP 4 — Decide
4A: For candidates for empiric supplementation, initiate age‑appropriate empiric vitamin D dosing (per guideline) without prior 25(OH)D testing.
4B: For those not meeting empiric supplementation criteria, do not order 25(OH)D testing and do not initiate empiric vitamin D supplementation; advise on dietary sources and safe sun exposure as needed.

## Clinical Guardrails / Mimics / Pitfalls
Do not use race as a proxy for dark complexion; assess skin pigmentation directly. Do not extrapolate to patients with conditions that alter vitamin D metabolism (e.g., malabsorption, renal disease). Do not order 25(OH)D testing based solely on skin complexion. Do not initiate high‑dose intermittent vitamin D without a specific indication. Do not assume low 25(OH)D levels based on complexion alone.

## Concrete Clinical Example
A 55‑year‑old African American woman with Fitzpatrick skin type VI presents for a routine preventive visit. She denies symptoms of hypocalcemia, malabsorption, or bone pain and asks whether she should be checked for vitamin D deficiency. Following the guideline, we advise against routine 25(OH)D screening; we note that empiric supplementation is not recommended for her age group without other indications, and we counsel on dietary vitamin D sources and safe sun exposure.

**Source:** Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2024, https://doi.org/10.1210/clinem/dgae290